Increased incidence of pregnancy complications in women who later develop scleroderma: A case control study

Arthritis Research and Therapy

Volumn 13, Issue 6, 2011, Pages

  van Wyk, Linda ^a   van der Marel, Jacolien ^a   Schuerwegh, Annemie J M ^a   Schouffoer, Anne A ^a   Voskuyl, Alexandre E ^b   Huizinga, Tom W J ^a   Bianchi, Diana W ^c   Scherjon, Sicco A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Chimerism; Hypertension; Intra uterine growth restriction; Pre eclampsia; Pregnancy; Systemic sclerosis

Indexed keywords

HLA ANTIGEN CLASS 2;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CELL MIGRATION; CHIMERA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS CELL; HUMAN; HYPERTENSION; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY COMPLICATION; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK; SCLERODERMA; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; CHILD; CLINICAL TRIAL; COMORBIDITY; MALE; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PREGNANCY;

ABORTION, SPONTANEOUS; ADULT; CASE-CONTROL STUDIES; CHILD; COMORBIDITY; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC;

EID: 80355132601     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3510     Document Type: Article

References (18)

1. Nelson JL. Microchimerism and the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 1998, 10:564-571. 10.1097/00002281-199811000-00010, 9812217.
2. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CW. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999, 45:184-188.
3. Zhong XY, Holzgreve W, Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 2002, 21:77-83. 10.1081/PRG-120002911, 12044339.
4. Levine RJ, Qian C, Leshane ES, Yu KF, England LJ, Schisterman EF, Wataganara T, Romero R, Bianchi DW. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004, 190:707-713. 10.1016/j.ajog.2003.12.019, 15042003.
5. Holzgreve W, Ghezzi F, Di Naro E, Ganshirt D, Maymon E, Hahn S. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998, 91:669-672. 10.1016/S0029-7844(98)00068-4, 9572208.
6. Lau TW, Leung TN, Chan LY, Lau TK, Chan KC, Tam WH, Lo YM. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002, 48:2141-2146.
7. Swinkels DW, de Kok JB, Hendriks JC, Wiegerinck E, Zusterzeel PL, Steegers EA. Hemolysis, elevated liver enzymes, and low platelet count HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002, 48:650-653.
8. Al-Mufti R, Lees C, Albaiges G, Hambley H, Nicolaides KH. Fetal cells in maternal blood of pregnancies with severe fetal growth restriction. Hum Reprod 2000, 15:218-221. 10.1093/humrep/15.1.218, 11041527.
9. Khosrotehrani K, Johnson KL, Lau J, Dupuy A, Cha DH, Bianchi DW. The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum 2003, 48:3237-3241. 10.1002/art.11324, 14613289.
10. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996, 93:705-708. 10.1073/pnas.93.2.705, 40117, 8570620.
11. O'Donoghue K, Chan J, de la Fuente J, Kennea N, Sandison A, Anderson JR, Roberts IA, Fisk NM. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 2004, 364:179-182. 10.1016/S0140-6736(04)16631-2, 15246731.
12. Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999, 93:2033-2037.
13. Nelson JL. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune?. Arthritis Rheum 1996, 39:191-194. 10.1002/art.1780390203, 8849367.
14. Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, Bean MA, Ober C, Bianchi DW. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998, 351:559-562. 10.1016/S0140-6736(97)08357-8, 9492775.
15. Ooki I, Takakuwa K, Akashi M, Nonaka T, Yokoo T, Tanaka K. Studies on the compatibility of HLA-Class II alleles in patient couples with severe pre-eclampsia using PCR-RFLP methods. Am J Reprod Immunol 2008, 60:75-84. 10.1111/j.1600-0897.2008.00592.x, 18593440.
16. Artlett CM, Welsh KI, Black CM, Jimenez SA. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 1997, 47:17-22. 10.1007/s002510050321, 9382916.
17. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011, 25:391-403. 10.1016/j.bpobgyn.2011.01.006, 21333604.
18. Ooki I, Takakuwa K, Akashi M, Nonaka T, Yokoo T, Tanaka K. Studies on the compatibility of HLA-Class II alleles in patient couples with severe pre-eclampsia using PCR-RFLP methods. Am J Reprod Immunol 2008, 60:75-84. 10.1111/j.1600-0897.2008.00592.x, 18593440.